| Heading |
Descriptor |
Yes/No |
Page/¶ |
N/A |
Comments |
| Title: |
1. Contents of manuscript clearly identified
within 135 character limit. |
________ |
________ |
________ |
________ |
| Abstract: |
2. Structured per Instructions for Authors. |
________ |
________ |
________ |
________ |
| |
3. Design identified as Case-control Study. |
________ |
________ |
________ |
________ |
| Introduction: |
4. Background for why study was conducted. |
________ |
________ |
________ |
________ |
|
5. Brief review of pertinent literature. |
________ |
________ |
________ |
________ |
| |
6. Statement of research question. |
________ |
________ |
________ |
________ |
| Methods: |
7. Definition and source of cases. |
________ |
________ |
________ |
________ |
| |
8. Diagnostic procedures to identify cases. |
________ |
________ |
________ |
________ |
|
9. Exclusion criteria for cases. |
________ |
________ |
________ |
________ |
| |
10. Information on whether cases are incident
or prevalent. |
________ |
________ |
________ |
________ |
| |
11. Definition and source of controls. |
________ |
________ |
________ |
________ |
| |
12. Time period used for identifying patients. |
________ |
________ |
________ |
________ |
| |
13. Statement whether cases and controls
underwent same diagnostic procedures. |
________ |
________ |
________ |
________ |
|
14. Exclusion criteria for controls. |
________ |
________ |
________ |
________ |
| |
15. Information on matching procedures, if
used. |
________ |
________ |
________ |
________ |
| |
16. Explain how exposure variables were
defined and ascertained. |
________ |
________ |
________ |
________ |
| |
17. Information on methods of data collection
(interview, questionnaire, record review). |
________ |
________ |
________ |
________ |
| |
18. Information on masking of observers to
case/control status when obtaining exposure history. |
________ |
________ |
________ |
________ |
|
19. Verify IRB permission for research, record
review, interviews, etc. |
________ |
________ |
________ |
________ |
| |
20. Description of sample size
calculation/assumptions. |
________ |
________ |
________ |
________ |
| |
21. Description of analytic methods/software. |
________ |
________ |
________ |
________ |
| |
22. Information on methods for dealing with
confounding variables. |
________ |
________ |
________ |
________ |
| Results: |
23. Information on exposure (duration,
intensity). |
________ |
________ |
________ |
________ |
|
24. Statement of response/
non response rate. |
________ |
________ |
________ |
________ |
| |
25. Presentation of adjusted analyses, if
used. |
________ |
________ |
________ |
________ |
| |
26. If both eyes of each patient were studied,
indicate whether they were analyzed separately or averaged or
methods used for correlated data. |
________ |
________ |
________ |
________ |
| |
27. Presentation of relative risk and
confidence limits. |
________ |
________ |
________ |
________ |
| Discussion: |
28. Statement of conclusions derived from
data. |
________ |
________ |
________ |
________ |
|
29. Compare and contrast results with previous
studies. |
________ |
________ |
________ |
________ |
| |
30. Discuss possible confounding variables and
study design limitations. |
________ |
________ |
________ |
________ |
| |
31. Information on investigation of possible
sources of bias. |
________ |
________ |
________ |
________ |
| |
32. Discuss biological plausibility of study
results. |
________ |
________ |
________ |
________ |
| |
33. Discuss applicability and generalizability
of results to clinical care if appropriate. |
________ |
________ |
________ |
________ |
|
34. Comment on need for future studies when
indicated. |
________ |
________ |
________ |
________ |
|
Form completed by: ________________________________________
|